A detailed history of Diligent Investors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Diligent Investors, LLC holds 4,871 shares of AMGN stock, worth $1.28 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
4,871
Previous 4,890 0.39%
Holding current value
$1.28 Million
Previous $1.53 Million 2.75%
% of portfolio
0.4%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $5,878 - $6,410
-19 Reduced 0.39%
4,871 $1.57 Million
Q2 2024

Jul 15, 2024

BUY
$262.75 - $319.31 $262 - $319
1 Added 0.02%
4,890 $1.53 Million
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $20,971 - $25,315
-78 Reduced 1.57%
4,889 $1.39 Million
Q4 2023

Jan 10, 2024

BUY
$255.7 - $288.46 $10,483 - $11,826
41 Added 0.83%
4,967 $1.43 Million
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $37,170 - $46,148
170 Added 3.57%
4,926 $1.32 Million
Q2 2023

Jul 24, 2023

BUY
$214.27 - $253.37 $642 - $760
3 Added 0.06%
4,756 $1.06 Million
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $94,831 - $115,584
420 Added 9.69%
4,753 $1.15 Million
Q4 2022

Jan 20, 2023

SELL
$229.03 - $291.01 $116,347 - $147,833
-508 Reduced 10.49%
4,333 $0
Q3 2022

Oct 14, 2022

BUY
$224.46 - $253.15 $210,094 - $236,948
936 Added 23.97%
4,841 $1.09 Million
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $180,876 - $201,284
-784 Reduced 16.72%
3,905 $950,000
Q1 2022

Apr 26, 2022

BUY
$219.27 - $242.57 $3,508 - $3,881
16 Added 0.34%
4,689 $1.13 Million
Q4 2021

Jan 21, 2022

BUY
$198.88 - $227.6 $290,961 - $332,978
1,463 Added 45.58%
4,673 $1.05 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $700 - $777
3 Added 0.09%
3,210 $783,000
Q1 2021

Apr 23, 2021

BUY
$221.91 - $258.6 $887 - $1,034
4 Added 0.12%
3,207 $798,000
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $649 - $773
3 Added 0.09%
3,203 $736,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $938 - $1,043
4 Added 0.13%
3,200 $813,000
Q2 2020

Jul 09, 2020

BUY
$197.81 - $242.74 $593 - $728
3 Added 0.09%
3,196 $754,000
Q1 2020

Apr 29, 2020

SELL
$182.24 - $241.7 $53,943 - $71,543
-296 Reduced 8.48%
3,193 $647,000
Q4 2019

Jan 13, 2020

SELL
$189.21 - $243.2 $42,004 - $53,990
-222 Reduced 5.98%
3,489 $841,000
Q3 2019

Oct 22, 2019

BUY
$174.11 - $208.62 $696 - $834
4 Added 0.11%
3,711 $718,000
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $6,334 - $7,425
38 Added 1.04%
3,707 $683,000
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $723 - $815
-4 Reduced 0.11%
3,669 $697,000
Q4 2018

Jan 17, 2019

SELL
$178.4 - $208.25 $62,083 - $72,471
-348 Reduced 8.65%
3,673 $715,000
Q3 2018

Oct 26, 2018

BUY
$185.29 - $208.89 $370 - $417
2 Added 0.05%
4,021 $834,000
Q2 2018

Jul 23, 2018

BUY
$166.05 - $186.51 $332 - $373
2 Added 0.05%
4,019 $742,000
Q1 2018

Apr 23, 2018

BUY
$169.43 - $198.0 $12,876 - $15,048
76 Added 1.93%
4,017 $685,000
Q4 2017

Feb 12, 2018

BUY
$168.79 - $188.59 $168 - $188
1 Added 0.03%
3,941 $685,000
Q3 2017

Nov 09, 2017

SELL
$167.29 - $191.0 $58,216 - $66,468
-348 Reduced 8.12%
3,940 $735,000
Q2 2017

Aug 11, 2017

BUY
N/A
4,288
4,288 $739,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Diligent Investors, LLC Portfolio

Follow Diligent Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diligent Investors, LLC with notifications on news.